HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Toots Its Own Horn On Safety Of Marketed Drugs, Imports

This article was originally published in The Tan Sheet

Executive Summary

FDA’s Global Engagement report describes the agency’s actions to protect the international supply chain. Meanwhile, the Advances in FDA’s Safety Program for Marketed Drugs report notes label changes and safety studies mandated under its post-market drug safety program.

You may also be interested in...



Regulatory News In Brief

FDA warns consumers of link between PPIs and clostridium difficile-associated diarrhea; FDA commissioner adopts transparency proposals; Wholistic Herbs herbal eye and nasal sprays on recall; more Regulatory News In Brief.

FDA Global Pharma Safety Plan Looks To Food Model

FDA seeks new authority over the international drug supply chain to support a global safety plan.

FDA Launches Safe Use Initiative; Details TBA Following Stakeholder Input

FDA expects to accomplish the goals of its Safe Use Initiative through a combination of voluntary moves by industry and regulatory activities

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS125122

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel